ZOPHREN 4 mg/5 ml, syrup bottle, 50 ml
Active ingredients: Ondansetron hydrochloride hydrate, Ondansetron
Commercialized according to BDPMDispensing in France: Prescription only
Syrupbottle, 50 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ZOPHREN 4 mg/5 ml, sirop
- Pharmaceutical form
- sirop
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre de 50 ml avec cuillère-mesure double polyéthylène
- Marketing authorisation holder
- SANDOZ
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jan 1998
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62518996CIP73416563CIP133400934165634Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE D'ONDANSÉTRON DIHYDRATÉsirop | 5 mg · 5 ml | SA |
| ONDANSÉTRONsirop | 4 mg · 5 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.